Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 605

1.

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

Gordillo V, del Amo J, Soriano V, González-Lahoz J.

AIDS. 1999 Sep 10;13(13):1763-9.

PMID:
10509579
[PubMed - indexed for MEDLINE]
2.

Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil.

Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, Silveira VL.

Braz J Med Biol Res. 2002 Oct;35(10):1173-81. Epub 2002 Oct 13.

PMID:
12424490
[PubMed - indexed for MEDLINE]
Free Article
3.

Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.

Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK; Protocol Teams of ACTG 384, ACTG 731 and A5031s.

AIDS Behav. 2004 Jun;8(2):141-50.

PMID:
15187476
[PubMed - indexed for MEDLINE]
4.

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25.

PMID:
9637576
[PubMed - indexed for MEDLINE]
5.

Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain).

Soto Blanco JM, Pérez IR, March JC.

Int J STD AIDS. 2005 Feb;16(2):133-8.

PMID:
15807941
[PubMed - indexed for MEDLINE]
6.

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.

García de Olalla P, Knobel H, Carmona A, Guelar A, López-Colomés JL, Caylà JA.

J Acquir Immune Defic Syndr. 2002 May 1;30(1):105-10.

PMID:
12048370
[PubMed - indexed for MEDLINE]
7.

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B; MANIF 2000 Study Group.

Antivir Ther. 2005;10(1):53-61.

PMID:
15751763
[PubMed - indexed for MEDLINE]
8.

Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.

Diabaté S, Alary M, Koffi CK.

AIDS. 2007 Aug 20;21(13):1799-803.

PMID:
17690579
[PubMed - indexed for MEDLINE]
9.

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA.

J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):386-95.

PMID:
10866231
[PubMed - indexed for MEDLINE]
10.

Adherence to highly active antiretroviral therapy in HIV-infected inmates.

Inés SM, Moralejo L, Marcos M, Fuertes A, Luna G.

Curr HIV Res. 2008 Mar;6(2):164-70.

PMID:
18336264
[PubMed - indexed for MEDLINE]
11.

Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.

Duong M, Piroth L, Grappin M, Forte F, Peytavin G, Buisson M, Chavanet P, Portier H.

HIV Clin Trials. 2001 Mar-Apr;2(2):128-35.

PMID:
11590521
[PubMed - indexed for MEDLINE]
12.
13.

Factors influencing adherence to highly active antiretroviral therapy in Spain.

Moralejo L, Inés S, Marcos M, Fuertes A, Luna G.

Curr HIV Res. 2006 Apr;4(2):221-7.

PMID:
16611060
[PubMed - indexed for MEDLINE]
14.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
[PubMed - indexed for MEDLINE]
15.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

PMID:
12027060
[PubMed - indexed for MEDLINE]
Free Article
16.

Factors associated with adherence to antiretroviral medication in HIV-infected patients.

Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF.

Int J STD AIDS. 2002 May;13(5):301-10.

PMID:
11972933
[PubMed - indexed for MEDLINE]
17.

Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire.

Eholié SP, Tanon A, Polneau S, Ouiminga M, Djadji A, Kangah-Koffi C, Diakité N, Anglaret X, Kakou A, Bissagnené E.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):355-8.

PMID:
17438479
[PubMed - indexed for MEDLINE]
18.

Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.

Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.

Antivir Ther. 2004 Oct;9(5):713-9.

PMID:
15535408
[PubMed - indexed for MEDLINE]
19.

[Impact of demographic and psychosocial factors on adherence to antiretroviral treatment].

Ruiz-Pérez I, Olry de Labry-Lima A, Prada-Pardal JL, Rodríguez-Baño J, Causse-Prados M, López-Ruz MA, Martín-Rico P, del Arco-Jiménez A, Pasquau-Liaño J, de la Torre-Lima J, López-Gómez M, Muñoz-Roca N, Marcos-Herrero M, Muñoz I, Morales-Rojas D.

Enferm Infecc Microbiol Clin. 2006 Jun-Jul;24(6):373-8. Spanish.

PMID:
16792939
[PubMed - indexed for MEDLINE]
20.

Assessing relationships between health-related quality of life and adherence to antiretroviral therapy.

Carballo E, Cadarso-Suárez C, Carrera I, Fraga J, de la Fuente J, Ocampo A, Ojea R, Prieto A.

Qual Life Res. 2004 Apr;13(3):587-99.

PMID:
15130023
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk